Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Mandatory Testing Urged for Mad Cow Disease

By HospiMedica staff writers
Posted on 19 Jan 2004
Unlike countries such as England and Japan whose reaction to finding bovine spongiform encephalopathy (BSE) in cows was to order mandatory testing of all slaughtered cattle intended for market, Canada and the United States are not testing all cows before they are sent to market, even though both countries have recently had a case of BSE, or mad cow disease.

Other steps taken by England and other countries as protective measures were to keep detailed records of all cows within their borders and to ban the use of all ruminant feed. More...
The high concentration of nerve and brain tissue in ruminant feed is thought to greatly increase the risk of transmission of mad cow disease. The United States and most other beef-producing countries have banned the use of ruminant feed, but there is currently no way to prevent small farmers from making and using ruminant feed. These criticisms were recently voiced by Ira Krull, Ph.D., a professor of chemistry at Northeastern University (Boston, MA, USA), echoing those of a number of U.S. consumer groups.

Only an estimated 0.03% of U.S. slaughtered cattle are randomly tested for mad cow disease. Currently, tests for BSE are effective only on slaughtered cattle because brain tissue is needed to make a diagnosis. Dr. Krull, together with Norman Chiu, Ph.D., assistant chemistry professor at Northeastern, are working to develop a clinical assay to detect chronic wasting disease, a variant of mad cow that affects deer and elk.

"The more cattle tested the more likely it is that some will be found with the disease,” noted Dr. Krull. "They don't want to find it. I don't believe we will see change until the beef industry is forced to be accountable for selling contaminated products to consumers.”




Related Links:
Northeastern

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.